Léčba recidiv karcinomu děložního hrdla
Title in English | The treatment of recurrent cervical cancer |
---|---|
Authors | |
Year of publication | 2010 |
Type | Article in Periodical |
Magazine / Source | Onkologie |
MU Faculty or unit | |
Citation | |
Field | Oncology and hematology |
Keywords | recurrence; cervical cancer; therapy |
Description | The recurrence rate of cervical cancer is between 10–20 % for FIGO stages IB–IIA and 50–70 % for FIGO stages IIB–IVA. When cervical cancer is beyond curative treatment by surgery or radiotherapy, the prognosis is poor. The patiens with recurrent cervical cancer have 1 year – survival rate between 15–20 %. Palliation therapy is the primary objective. Recurrent lesions not amenable to radical local exscision or regional radiation are treated with paliative chemotherapy. Low response and short overall survival are disappointing. The need for novel agents and further research focused on the management of recurrent cervical cancer remains. For future trials it is necessary to incorporate biological agents to chemotherapy. |